Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

Targeted screening to participants in ≥90th percentile of polygenic risk score results in detection of cancer warranting clinical management in 55.1 percent.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Lara Rodriguez Sanchez, Samir Taneja, Hashim Ahmed, Himanshu Nagar, Edward Schaeffer in a Crossfire: Controversies in Urology debate: discussed if Focal Therapy is a Suitable Option for all Cases with ...

At the 38th Annual Meeting of the Engineering & Urology Society (EUS), Mr. Dan Luca of UCLA presented a compelling advancement in the imaging of prostate cancer (PCa), identifying prostate ductal ...